“MAIA continues to bring innovation to the biotech industry as one of the earliest pioneers of telomere targeting as a strategy for cancer treatment. Our lead candidate is THIO (ateganosine ...

MAIA Biotechnology, Inc. (NYSEAMERICAN ... The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with ...

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) stands against other ...

Investors might want to bet on MAIA Biotechnology, Inc. (MAIA), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

Maia Walsh was found dead at her home in Hertford on 6 October 2022 and had been watching “concerning” content on TikTok in the run-up to her death, a pre-inquest review hearing heard on ...

CINCINNATI (Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large investment in Greater Cincinnati a little over a year ago has unveiled new ...

He has since removed his account on LinkedIn. Ms Stefanie Yuen-Thio, joint managing partner at TSMP Law Corporation, said she is glad the Law Society has taken definitive action. “We need to be ...

MAIA Biotechnology is an immuno-oncology company specializing in targeted therapies aimed at enhancing the treatment of cancer. Its primary candidate, THIO, is a novel drug in clinical trials ...